Ra Capital Management, L.P. Portfolio Holdings

Ra Capital Management, L.P.

  • $6.17 Billion
  • Q4 2024

Ra Capital Management, L.P. has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $6.17 Billion distributed in 90 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ascendis Pharma A/S with a value of $1.39B, Vaxcyte, Inc. with a value of $711M, Janux Therapeutics, Inc. with a value of $555M, Rhythm Pharmaceuticals, Inc. with a value of $340M, and Legend Biotech Corp with a value of $244M.

Examining the 13F form we can see an decrease of $997M in the current position value, from $7.17B to 6.17B.

Ra Capital Management, L.P. is based out at Boston, MA

Below you can find more details about Ra Capital Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $6.17 Billion
Healthcare: $6.06 Billion
ETFs: $111 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$11B
$13.8 Million 0.22% of portfolio
200,000
Q2 2024 New

Summary

  • Portfolio
  • No. of Stocks 90
  • Current Value $6.17 Billion
  • Prior Value $7.17 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 17 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 16 stocks
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email